End Stage Renal Disease Market Size & Share Report, 2032

End Stage Renal Disease Market Size By Treatment (Transplant, Dialysis), By Diagnosis (Blood Test, Urine Test, Imaging Test), By End-use (Hospital and Clinics, Dialysis Centres), & Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data Sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; End stage renal disease industry 360&ordm; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Treatment trends

2.5&nbsp;&nbsp;&nbsp; Diagnosis trends

2.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;End Stage Renal Disease Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising number of end stage renal diseases (ESRD) patients

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancement in diagnostic and treatment devices

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing prevalence of diabetes and hypertension

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of equipments

3.2.2.2&nbsp;&nbsp;&nbsp;Complications associated with the treatment of ESRD

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By treatment

3.3.2&nbsp;&nbsp;&nbsp; By diagnosis

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Key market trends

3.7&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.8&nbsp;&nbsp;&nbsp; Technology landscape

3.9&nbsp;&nbsp;&nbsp; Future market trends

3.10&nbsp;&nbsp;&nbsp; Value chain analysis

3.11&nbsp;&nbsp;&nbsp; Gap Analysis

3.12&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Global company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Vendor matrix analysis

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;End Stage Renal Disease Market Size and Forecast, By Treatment (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by treatment

5.2&nbsp;&nbsp;&nbsp; Transplant

5.3&nbsp;&nbsp;&nbsp; Dialysis

5.3.1&nbsp;&nbsp;&nbsp; Hemodialysis

5.3.2&nbsp;&nbsp;&nbsp; Peritoneal Dialysis

Chapter 6&nbsp;&nbsp;&nbsp;End Stage Renal Disease Market Size and Forecast, By Diagnosis (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by diagnosis

6.2&nbsp;&nbsp;&nbsp; Blood Test

6.3&nbsp;&nbsp;&nbsp; Urine Test

6.4&nbsp;&nbsp;&nbsp; Imaging Test

6.5&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;End Stage Renal Disease Market Size and Forecast, By End-use (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Dialysis centers

7.4&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;End Stage Renal Disease Market Size and Forecast, By Region (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Sweden

8.3.7&nbsp;&nbsp;&nbsp; Poland

8.3.8&nbsp;&nbsp;&nbsp; The Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Indonesia

8.4.7&nbsp;&nbsp;&nbsp; Thailand

8.4.8&nbsp;&nbsp;&nbsp; Philippines

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Colombia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

8.6.5&nbsp;&nbsp;&nbsp; Egypt

8.6.6&nbsp;&nbsp;&nbsp; Turkey

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; AngioDynamics, Inc.

9.2&nbsp;&nbsp;&nbsp; Asahi Kasei Medical Co., Ltd.

9.3&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

9.4&nbsp;&nbsp;&nbsp; Baxter International, Inc.

9.5&nbsp;&nbsp;&nbsp; Becton Dickinson and Company

9.6&nbsp;&nbsp;&nbsp; Cantel Medical

9.7&nbsp;&nbsp;&nbsp; DaVita Inc.

9.8&nbsp;&nbsp;&nbsp; Fresenius Medical Care AG &amp; Co. KGaA

9.9&nbsp;&nbsp;&nbsp; JMS Co. Ltd.

9.10&nbsp;&nbsp;&nbsp; Medtronic Plc

9.11&nbsp;&nbsp;&nbsp; Nikkiso Co., Ltd.

9.12&nbsp;&nbsp;&nbsp; Nipro Corporation

9.13&nbsp;&nbsp;&nbsp; Teleflex Incorporated

9.14&nbsp;&nbsp;&nbsp; Toray Industries Inc.

9.15&nbsp;&nbsp;&nbsp;U.S. Renal Care, Inc. 
&nbsp;

End Stage Renal Disease Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters